Non-steroidal anti-inflammatory drugs amid COVID-19 pandemic: An ally or an enemy?

Authors

  • Azhar Hussain Franklin University, Ohio
  • Jasndeep Kaler Xavier University School of Medicine, Oranjestad
  • Sohail Kumar Dow Medical College, Dow University of Health Sciences, Karachi
  • Dua Azim Dow Medical College, Dow University of Health Sciences, Karachi
  • Sundus Nasim Dow University of Health Sciences

DOI:

https://doi.org/10.3329/bjid.v8i1.49980

Keywords:

SARS-CoV-2; NSAIDS; ACE2; COVID-19

Abstract

As the current global pandemic of the novel coronavirus diseases 2019 (COVID-19) continues to rage, the scientific and medical worlds are working to establish an effective therapy against the illness. Recently questions regarding non-steroidal anti-inflammatory drugs (NSAIDs) as a potential therapeutic option for COVID-19 have surfaced. While some studies hint towards the possible benefit of NSAIDs against SARS-CoV-2 infection, the current body of evidence also sheds light on the potential risk of using NSAIDs in COVID-19 patients. Thus, the available literature does not provide conclusive evidence for or against the use of NSAIDs for treating COVID-19 patients. Given the limited data available, we suggest cautionary approaches for the public to avoid possible harm until further evidence emerges. NSAIDs should not be used as the first-line agents for COVID-19 unlessunder medical supervision. Moreover, patients with chronic inflammatory conditions should continue the NSAIDs as per their regular prescriptions.

Bangladesh Journal of Infectious Diseases 2021;8(1): 50-52

Downloads

Download data is not yet available.
Abstract
171
PDF
169

Author Biography

Azhar Hussain, Franklin University, Ohio

Doctoral Candidate of HealthCare Administration

Downloads

Published

2022-01-30

How to Cite

Hussain, A., Kaler, J., Kumar, S., Azim, D., & Nasim, S. (2022). Non-steroidal anti-inflammatory drugs amid COVID-19 pandemic: An ally or an enemy?. Bangladesh Journal of Infectious Diseases, 8(1), 50–52. https://doi.org/10.3329/bjid.v8i1.49980

Issue

Vol. 8 No. 1 (2021)

Section

Perspective

License

Copyright (c) 2021 Azhar Hussain, Jasndeep Kaler, Sohail Kumar, Dua Azim, Sundus Nasim

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright

Copyright on any research article in the Bangladesh Journal of Infectious Diseases is retained by the author(s).

The authors grant the Bangladesh Infection Research Association a license to publish the article and identify itself as the original publisher.

Articles in the Bangladesh Journal of Infectious Diseases are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)

This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.